Rockwell Medical, Inc. (RMTI) vs SCYNEXIS, Inc. (SCYX)
A side-by-side comparison of Rockwell Medical, Inc. and SCYNEXIS, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
RMTI
Rockwell Medical, Inc.
$7.65HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
SCYX
SCYNEXIS, Inc.
$4.84HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — RMTI vs SCYX
growth of $100 · dividends reinvested · last 10yRMTI -98.9% (-36.3%/yr)SCYX -98.7% (-35.2%/yr)SCYX compounded faster over this window
RMTI SCYX
RMTI vs SCYX: by the numbers
- •SCYX is the larger company ($30M vs $30M market cap).
- •Both run net losses; RMTI's is the smaller (-7.33% vs -53.27% net margin).
- •SCYX grew revenue faster over the past five years (9.78% vs 2.59% CAGR).
Metrics side by side
Valuation
| Metric | RMTI | SCYX |
|---|---|---|
| P/S ratio | 0.44 | 1.58 |
| P/B ratio | 0.86 | 0.45 |
| FCF yield | 5.10% | N/A |
Profitability
| Metric | RMTI | SCYX |
|---|---|---|
| Gross margin | 17.71% | 100.00% |
| Operating margin | -6.52% | -78.03% |
| Net margin | -7.33% | -53.27% |
| ROE | -14.49% | -15.29% |
| ROIC | -9.60% | -32.68% |
Growth (annualized)
| Metric | RMTI | SCYX |
|---|---|---|
| Revenue CAGR (5Y) | 2.59% | 9.78% |
| Total return CAGR (5Y) | -33.38% | -34.13% |
Frequently asked
- Which has grown faster, RMTI or SCYX?
- Over the past five years, SCYX grew revenue faster — RMTI at a 2.59% CAGR versus SCYX at 9.78%.
- How have RMTI and SCYX total returns compared?
- Over the past 10 years, RMTI delivered -36.28% and SCYX delivered -35.18% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Rockwell Medical ROESCYNEXIS ROERockwell Medical operating marginSCYNEXIS operating marginRockwell Medical revenue growthSCYNEXIS revenue growthRockwell Medical free cash flowSCYNEXIS free cash flow
Rockwell Medical & SCYNEXIS appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.